227 related articles for article (PubMed ID: 11992749)
1. Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease.
Aisen PS
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S35-40. PubMed ID: 11992749
[TBL] [Abstract][Full Text] [Related]
2. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
Aisen PS; Schafer KA; Grundman M; Pfeiffer E; Sano M; Davis KL; Farlow MR; Jin S; Thomas RG; Thal LJ;
JAMA; 2003 Jun; 289(21):2819-26. PubMed ID: 12783912
[TBL] [Abstract][Full Text] [Related]
3. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.
McGeer PL
Drugs Aging; 2000 Jul; 17(1):1-11. PubMed ID: 10933512
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.
Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
Curr Drug Targets; 2003 Aug; 4(6):461-8. PubMed ID: 12866660
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
Pasinetti GM
J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
[TBL] [Abstract][Full Text] [Related]
6. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
Hochberg MC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
[TBL] [Abstract][Full Text] [Related]
7. Current perspective on the cardiovascular effects of coxibs.
Konstam MA; Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
[TBL] [Abstract][Full Text] [Related]
8. Emerging options with coxib therapy.
Lema MJ
Cleve Clin J Med; 2002; 69 Suppl 1():SI76-84. PubMed ID: 12086298
[TBL] [Abstract][Full Text] [Related]
9. Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study.
Reines SA; Block GA; Morris JC; Liu G; Nessly ML; Lines CR; Norman BA; Baranak CC;
Neurology; 2004 Jan; 62(1):66-71. PubMed ID: 14718699
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of selective COX-2 inhibitors.
Capone ML; Tacconelli S; Sciulli MG; Patrignani P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease, cancer and the search for a better aspirin. Postgraduate course at Mount Sinai School of Medicine, New York, NY June 22-23, 2001.
Scriabine A
CNS Drug Rev; 2001; 7(3):346-52. PubMed ID: 11775585
[No Abstract] [Full Text] [Related]
12. Clinical implications of selective cyclooxygenase-2 inhibition.
Emery P
Scand J Rheumatol Suppl; 1996; 102():23-8. PubMed ID: 8628978
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology and clinical action of COX-2 selective NSAIDs.
Bovill JG
Adv Exp Med Biol; 2003; 523():201-14. PubMed ID: 15088852
[No Abstract] [Full Text] [Related]
14. Renal effects of cyclooxygyenase-2-selective inhibitors.
Brater DC
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S15-20; discussion S21-3. PubMed ID: 11992745
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory drugs and their mechanism of action.
Vane JR; Botting RM
Inflamm Res; 1998 Oct; 47 Suppl 2():S78-87. PubMed ID: 9831328
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory drugs: a hope for Alzheimer's disease?
Hüll M; Lieb K; Fiebich BL
Expert Opin Investig Drugs; 2000 Apr; 9(4):671-83. PubMed ID: 11060701
[TBL] [Abstract][Full Text] [Related]
17. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
18. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase inhibition and thrombogenicity.
Catella-Lawson F; Crofford LJ
Am J Med; 2001 Feb; 110 Suppl 3A():28S-32S. PubMed ID: 11173047
[TBL] [Abstract][Full Text] [Related]
20. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
